AzTrials
AzTrials

FibromyalgiaNCT03778385

Influence of Exercise Type, Pain Mechanisms, and Biopsychosocial Contributions to Pain Relief in Those With Fibromyalgia

A study testing Exercise in people with Fibromyalgia, run by Marquette University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the influence different types of exercise, pain mechanisms, and biopsychosocial contributions on how people with and without fibromyalgia report pain. Exercise will be performed with the arm at a submaximal intensity. Read more about this study

Who is it for?
Ages 18 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Fibromyalgia
What is being tested?
Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
99 participants
Where
1 siteUnited States
Study dates
3 Feb 2017to Jan 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Fibromyalgia
  • Healthy Controls without fibromyalgia
  • Stable medical management plan for four weeks prior to participation in the study.
  • Physical Activity Readiness Questionnaire (PAR-Q)
  • English proficiency

Who cannot join

  • Elbow arthritis
  • Carpal tunnel syndrome
  • Cervical surgery
  • Cerebrovascular accident / stroke
  • Multiple sclerosis
  • Parkinson's disease
Show all 24Show fewer
  • Any central neurodegenerative disease
  • Traumatic brain injury
  • Peripheral neuropathy of the upper extremity
  • Myocardial infarction
  • Chronic obstructive pulmonary disease
  • Any unstable medical or psychiatric condition
  • Diabetes mellitus
  • Active cancer
  • Lymphedema of the upper extremity
  • Claustrophobia
  • Raynaud's phenomenon
  • Osteoporosis
  • Major depressive disorder
  • Bipolar disorder
  • Rheumatoid arthritis
  • Lupus
  • Polymyalgia rheumatica
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Marquette University

    Milwaukee, Wisconsin, 53233

Other trials in United States

About this study

Official title: Exercise Specificity and Endogenous Pain Modulation

The purpose of this study is to investigate the influence different types of exercise, pain mechanisms, and biopsychosocial contributions on how people with and without fibromyalgia report pain. Exercise will be performed with the arm at a submaximal intensity. Participants will undergo a variety of pain assessments, including clinical questionnaires and pain perception. This study will improve our understanding of how people with and without fibromyalgia respond to different resistance exercise types and whether physical activity and body composition has an influence on the response.

Read the detailed description

Fibromyalgia is a chronic widespread pain condition that is mostly prevalent in middle-aged women. Exercise is one of the few therapies that can alleviate fibromyalgia symptoms. Despite exercise being a major component of rehabilitation, exercise guidelines are unclear, often leading to symptom exacerbation and low compliance. Previous research has demonstrated that women with fibromyalgia may have different post-exercise pain responses when undergoing an exercise task. Factors critical to optimal exercise prescription are not known, including the most effective type of exercise, mechanisms responsible for pain relief, and biopsychosocial influences. This study investigates the use of exercise as a nonpharmacological pain management tool for people with fibromyalgia.

The purpose of this study is to investigate the acute exercise-induced pain response after isometric and dynamic muscle contractions in people with and without fibromyalgia. All participants will attend up to three sessions with approximately one week between sessions at a metropolitan university laboratory setting. Participants will perform different types of submaximal exercise for a maximum of ten minutes and complete pain assessments each session. Pain and psychosocial influences are measured with multiple established clinical questionnaires. Pressure pain sensitivity is tested by application of a mechanical stimulus to the arms and legs. To investigate a participant's innate ability to inhibit pain, the mechanical stimulus will be assessed with and without limb submersion in a cold-water bath. Physical activity is measured via questionnaire and use of activity monitors, while body composition is measured with a dual energy x-ray absorptiometry scan.

Conditions
Fibromyalgia
Being tested
Exercise
Keywords
Fibromyalgia, Exercise, Pain, Physical Activity, Body Composition
Medical subject headings
Fibromyalgia, Motor Activity, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExerciseOther

    Submaximal exercise is performed in randomized order with the participant seated and the arm supported in an adjustable hand-arm orthosis.

Study groups in NCT03778385
Study groupRoleWhat they receive
Isometric ExerciseExperimentalSubmaximal isometric resistance exercise of the arm.
Receives: Other: Exercise
Dynamic ExerciseExperimentalSubmaximal dynamic resistance exercise of the arm.
Receives: Other: Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline Short-Form McGill Pain Questionnaire to 7-days after performance of exercise.

    The Short-Form McGill Pain Questionnaire is a multi-dimensional tool to assess pain quality in chronic pain patients. Participants rate the intensity of pain and related symptoms they felt during the past week on 0 to 3 scale, with 0 being no pain and 3 being severe. The total score ranges from a minimum of 0 to maximum 45 with higher scores indicating worse symptoms.

    Measured: Before and up to 7-days after performance of exercise.

  2. Change from Baseline Fibromyalgia Impact Questionnaire to 7-days after performance of exercise.

    The Fibromyalgia Impact Questionnaire - Revised measures function, overall impact, and symptoms of fibromyalgia. Participants rate the difficulty in performing daily tasks, the impact of their symptoms, and intensity of fibromyalgia symptoms on a 0 to 10 scale, with 10 signifying greater significance. The total score ranges from a minimum of 0 to maximum of 210 with higher scores indicating worse function and symptoms.

    Measured: Before and up to 7-days after performance of exercise.

  3. Change from Baseline Pain Rating from a Pressure Pain Device to immediately after performance of exercise.

    Application of mechanical stimulus through a weighted Lucite edge will be applied to the finger for a maximal duration of 2 minutes. Subjects will provide a pain rating every 20 seconds during the 2-minute test. Pain ratings are provided with use of a Numerical Pain Rating Scale that ranges from 0 (no pain) to 10 (worst pain).

    Measured: Before and immediately after performance of exercise.

  4. Change from Baseline Pressure Pain Threshold to immediately after performance of exercise.

    Application of a pressure stimulus is applied to the bicep muscle and quadriceps muscle at a rate of 50kPa per second until the pressure first becomes painful.

    Measured: Before and immediately after exercise.

  5. Change from Baseline Numerical Pain Rating Scale to 7-days after performance of exercise.

    Pain in the exercising limb and whole body will be reported. Pain ratings are provided with use of a Numerical Pain Rating Scale that ranges from 0 (no pain) to 10 (worst pain).

    Measured: Before, during, and up to 7-days after performance of exercise.

  6. Change in Pain Catastrophizing before to after exercise.

    Measures the exaggerated negative mental set brought to bear during an actual or anticipated painful experience. Measured with the Pain Catastrophizing Scale which has subscales of rumination, magnification, and helplessness. Rumination scale ranges from 0 to 16 with higher score indicating higher levels of rumination. Magnification scale ranges from 0 to 12 with higher scores indicating higher levels of magnification. Helplessness scale ranges from 0 to 24 with higher scores indicating higher levels of helplessness. The subscale scores are summed to compute a total score ranging from 0 to 52 with higher scores indicating higher levels of pain catastrophizing.

    Measured: Through study completion, an average of 3 weeks.

  7. Baseline Tampa Scale of Kinesiophobia - 11

    Measures pain-related fear in relation to movement or avoidance type behaviors. A total score is computed ranging from 0 to 44 with higher scores indicating higher levels of pain-related fear.

    Measured: At the beginning of each session.

  8. Change from Baseline PROMIS Short Form v1.0 - Fatigue 7a at completion of study.

    Measures the experience and impact of fatigue on daily activity. The PROMIS Short Form v1.0 - Fatigue 7a measures subjective feelings of tiredness to a sense of exhaustion that likely decreases one's ability to execute daily activities and function normally in family or social roles. Participants rank the level of tiredness on a scale of 1 (never) to 5 (always). The total score ranges from 7 to 35 with 35 indicating greater levels of exhaustion that impacts ability to perform daily tasks.

    Measured: At the beginning of each exercise session.

  9. American College of Rheumatology Diagnostic Criteria for Fibromyalgia

    Questionnaire characterizing the symptoms of those with fibromyalgia. The scale is composed of 3 subscales; widespread pain index, symptom severity score A and B. The widespread pain index ranges from 0 to 19 with 19 indicating greater number of body areas in which pain was experienced. The symptom severity score A ranges from 0 to 9 with 9 indicating greater symptom severity. The symptom severity score B ranges from 0 to 3 with 3 indicating greater number of symptoms experienced. The total Symptom Severity Score is calculated by adding symptom severity score A and symptom severity score B with a total range of 0 (no symptoms) to 12 (great deal of symptoms).

    Measured: At the beginning of each session.

  10. Conditioned Pain Modulation

    The difference in pressure pain (measured via pressure algometry) at the biceps and quadriceps with and without the subject's limb placed in an ice water bath.

    Measured: Day 1 of enrollment

  11. Physical Activity Assessment Tool

    The Physical Activity Assessment Tool estimates the amount of physical activity performed and perceptions towards participation in physical activity. The total amount of time per day (minutes/day) is calculated for time spent in moderate to vigorous physical activity. With 0 minutes indicating no time spent in moderate to vigorous physical activity and higher values indicating greater time spent in moderate to vigorous physical activity.

    Measured: Up to 7 days.

  12. Total time spent in sedentary and moderate to vigorous physical activity measured by an Actigraph wGT3x over the course of 7 days.

    An Actigraph wGT3x is a wrist worn device that is used to track the amount and intensity of physical activity performed over the course of seven days. Total time spent in sedentary and moderate to vigorous physical activity is measured in minutes.

    Measured: Worn continuously for a 7-day period during study enrollment.

  13. Baseline Lean Mass

    Measurement of lean mass with use of dual energy x-ray absorptiometry testing.

    Measured: 7 to 14 days after enrollment.

  14. Baseline Fat Mass

    Measurement of fat mass with use of dual energy x-ray absorptiometry testing.

    Measured: 7 to 14 days after enrollment.

Secondary outcomes (8)
  1. Change from Baseline Maximal Voluntary Force to immediately after performance of exercise.

    Maximal force produced with the arm when performing a bending motion of the elbow. Maximal torque is measured with an isokinetic dynamometer with higher levels indicating greater amount of force.

    Measured: Before and immediately after performance of exercise.

  2. Baseline voluntary muscle activation of the biceps muscle

    Assess each subject's ability to voluntarily activate their bicep muscle when performing a maximal voluntary contraction of the elbow flexors. Participants will generate maximal force from their elbow flexors with application of muscle stimulation. Muscle stimulation is provided via electrodes placed on the skin overlying the biceps muscle and activation of the muscle will be achieved by a constant-current stimulator. Force is recorded via isokinetic dynamometry. To assess voluntary activation, a single twitch will be interpolated during the plateau of the maximal voluntary contraction force by the stimulator.

    Measured: Through study completion, an average of 3 weeks.

  3. Change from Baseline Heart Rate to immediately after performance of exercise.

    Heart rate is measured with an automated cuff applied to the wrist.

    Measured: Measured before, during, and immediately after exercise.

  4. Change from Baseline Blood Pressure to immediately after performance of exercise.

    Blood pressure is measured with an automated cuff applied to the wrist.

    Measured: Measured before, during, and immediately after exercise.

  5. Change from Baseline Rating of Perceived Exertion to immediately after performance of exercise

    Rating of Perceived Exertion refers to the total amount of exertion a participant is feeling and measured with a modified BORG scale ranging from 0 (nothing) to 10 (maximal exertion).

    Measured: Measured before, during, and immediately after exercise.

  6. Baseline sensory threshold assessed with von Frey monofilaments

    Monofilaments will be applied perpendicular to the skin in ascending order, the lowest-size filament to induce sensation is recorded.

    Measured: At the beginning of each session.

  7. Change from baseline pain unpleasantness up to 7 days after exercise.

    Unpleasantness in the exercising limb will be reported with a 0-10 numerical rating scale.

    Measured: Before, during, and up to 7-days after performance of exercise.

  8. Change from baseline PROMIS Short Form v1.0 Pain Interference 6b up to 7 days after exercise.

    A 6-item questionnaire will help measure interference of pain on functional daily activity.

    Measured: Before, during, and up to 7-days after performance of exercise.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2018
  2. Study start3 Feb 2017
  3. Primary completionJan 2023 (estimated)
  4. Study completionJan 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
All subjects will participate in two randomized exercise sessions. Clinical and experimental pain assessment will be performed before, during, and after each exercise task.
Masking
Single blind
Who is masked
Participant
Enrolment
99 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03778385
Sponsor's protocol ID
HR-3035
Other IDs
R15HD090265, TL1TR001437, UL1TR001436
Status last verified
Jun 2022
First submitted
12 Dec 2018
Last updated
7 Jun 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Berardi G, Eble C, Hunter SK, Bement MH. Localized Pain and Fatigue During Recovery From Submaximal Resistance Exercise in People With Fibromyalgia. Phys Ther. 2023 Jun 5;103(6):pzad033. doi: 10.1093/ptj/pzad033.

    PubMed 37384640

Questions about this trial

What is this clinical trial studying?

A study testing Exercise in people with Fibromyalgia, run by Marquette University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 24 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline Short-Form McGill Pain Questionnaire to 7-days after performance of exercise. (time frame: Before and up to 7-days after performance of exercise.). The study lists 14 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03778385, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in